Effector ExoU from the Type III Secretion System Is An Important Modulator of Gene Expression in Lung Epithelial Cells in Response to Pseudomonas aeruginosa Infection.

Decreased enrollment in breast cancer trials by histologic subtype: does invasive lobular carcinoma resist RECIST?

Lauren Hunt gave talk to Duke-UNC Alzheimer’s Disease Research Center IDEAS Forum

Lauren Hunt, PhD, RN, FNP gave a talk to the Duke-UNC Alzheimer’s Disease Research Center IDEAS Forum entitled: “Dying with Dementia: Is Hospice the Answer?” In this talk, she discussed the end-of-life experience of people with dementia, patterns and outcomes of hospice use, and implications for clinicians and researchers.

An overview of the human interleukin-2 receptor: molecular, biochemical, and functional properties.

Adrenergic hormones and control of cardiac myocyte growth.

Changing resident test ordering behavior: a multilevel intervention to decrease laboratory utilization at an academic medical center.

Monitoring acute metabolic changes in the liver and kidneys induced by fructose and glucose using hyperpolarized [2-13 C]dihydroxyacetone.

Introducing the inaugural issue of Health Affairs Scholar: Emerging and Global Health Policy (HAS).

Exceptional Response to Bromodomain and Extraterminal Domain Inhibitor Therapy With BMS-986158 in BRD4-NUTM1 NUT Carcinoma Harboring a BRD4 Splice Site Mutation.

Pulmonary Hypertension Due to Left Heart Disease: an Update.

A Survey Of Health Information Exchange Organizations In Advance Of A Nationwide Connectivity Framework.

Dr. Janice Schwartz Awarded 2019 PhRMA Foundation Award in Excellence in Clinical Pharmacology.

Congratulations to Dr. Janice Schwartz for being awarded the 2019 PhRMA Foundation Award in Excellence in Clinical Pharmacology. 

Once each year, the PhRMA Foundation grants Awards in Excellence to past Foundation awardees who are living and dramatic proof that the Foundation program works and makes a difference. Each Award in Excellence recipient received a Foundation grant at the outset of his or her career and went on to a distinguished career of scientific and/or academic achievements in different areas: clinical pharmacology, pharmacology/toxicology and pharmaceutics. The criterion is simply “excellence” in their career.

Thrombin-cleaved osteopontin regulates hemopoietic stem and progenitor cell functions through interactions with alpha9beta1 and alpha4beta1 integrins.

Systematic Review: Targeting HER2 in Bladder Cancer

Pembrolizumab for the treatment of non-small-cell lung cancer.